Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
VREX · against 588 other Healthcare companies listed in US-listed
Ranked #87 of 589 · scores higher than 85% of peers
Bars: peers in each 10-point band of the valuation score45 peers with a valuation score of 60–69, including VREX · Click a bar to see the companies
Mainly thanks to its EBITDA yield and earnings yield, which are stronger than most Healthcare peers.
| Metric | VREX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 577 reported | 2.9% | -4.3% | 78% | 30% | |
| EBITDA yieldHigher is better · 578 reported | 9.3% | -0.8% | 85% | 50% | |
| Free cash flow yieldHigher is better · 553 reported | -2.6% | -2.3% | 49% | 20% | |
| Book yieldHigher is better · 587 reported | 63.6% | 25.9% | 81% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 256M USD | 98 | 80 | |
| 2 | 595M USD | 96 | 97 | |
| 2 | 433M USD | 96 | 81 | |
| 2 | 289M USD | 96 | 57 | |
| 2 | 810M USD | 96 | 69 | |
| 80 | 25.8B USD | 70 | 75 | |
| 87 | 9.0B USD | 69 | 57 | |
| 87 | 9.2B USD | 69 | 47 | |
| 87 | 4.8B USD | 69 | 52 | |
| 87 | 787M USD | 69 | 57 | |
| 91 | 2.4B USD | 68 | 64 | |
| 91 | 1.4B USD | 68 | 42 | |
| 91 | 302.7B USD | 68 | 63 | |
| 91 | 32.8B USD | 68 | 69 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score